Theravasc
Cleveland · Founded 2009
About Theravasc
TheraVasc, Inc., a biotechnology company, develops repurposed drugs for vascular disease markets. It offers TV1001, an oral formulation of sodium nitrite that targets patient populations with poor blood flow to the extremities, such as those with diabetic leg and foot problems, and peripheral artery disease. The company was incorporated in 2009 and is based in Cleveland, Ohio.
Company Facts
- Founded: 2009
- Legal name: Theravasc, Inc
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $3.4M
- Last round: Series Unknown (Nov 2016)
- Website: theravasc.com
- Phone: +1 318-349-3851
Social Profiles
Canonical: https://fsome.com/organization/theravasc-8421174 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.